Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 409-415, April 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chirigos, M. A.
Right arrow Articles by Goldin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chirigos, M. A.
Right arrow Articles by Goldin, A.

Therapeutic and Immunological Response of Mice with Meningeal Leukemia (L1210) to Challenge with an Antifolic-resistant Variant

M. A. Chirigos, L. B. Thomas, S. R. Humphreys, J. P. Glynn and A. Goldin

( Drug Evaluation Branch, Cancer Chemotherapy, National Service Center, and Pathologic Anatomy Branch, National Cancer Institute,* Bethesda, Maryland)

Augmentation of the therapeutic effectiveness of 3'-bromo-5'-chloroamethopterin (BCM) against the BCM-resistant variant of leukemia L1210 was demonstrated in mice given preinoculations intracerebrally of the sensitive parental line of leukemia L1210. Substantial increases in survival time were obtained, and in some cases these increases were almost as extensive as those observed when mice with sensitive leukemia L1210 alone were treated. The results indicated that the defense mechanism of the host in response to the preinoculation of L1210 contributed to the therapeutic efficacy of the drug against the resistant variant.

Mice immunized with x-radiated leukemia L1210 were capable of suppressing both subcutaneous and intracerebral inoculations of L1210. Substantial increases in survival time occurred, and several tumor-free survivors were obtained. Pathological study of meningeal leukemia showed that the leukemic deposits tended to be more localized in the immunized animals than in the nonimmunized animals. Leukemic cell infiltration into the retro-orbital tissues produced proptosis of the eyes in a few of the immunized mice.

When immunity was induced by the preinoculation of x-radiated leukemic cells there was a considerable enhancement of the effectiveness of chemotherapy. The combination of immunization and chemotherapy produced more extensive increases in survival time and a higher percentage of apparently tumor-free survivors than did either chemotherapy alone or immunization alone.

* Formerly Biochemical Pharmacology.

Received 8/28/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.